woad
root
use
prevent
influenza
hundr
year
mani
asian
countri
studi
antivir
mode
clemastanin
b
cb
epigoitrin
phenylpropanoid
portion
pep
mixtur
phenylpropanoid
alkaloid
organ
acid
portion
pep
alk
oa
wood
root
extract
influenza
viru
investig
result
reveal
cb
epigoitrin
pep
pep
alk
oa
exert
antiinfluenza
activ
via
inhibit
viru
multipl
prophylaxi
block
viru
attach
primari
mode
action
pep
pep
alk
oa
inhibit
viru
replic
inhibitori
effect
viru
attach
multipl
main
mode
epigoitrin
compound
chemic
portion
woad
root
extract
test
studi
direct
virucid
activ
result
provid
comprehens
analysi
antivir
mechan
wood
root
extract
influenza
flu
one
signific
acut
respiratori
diseas
caus
infect
influenza
viru
season
influenza
affect
million
peopl
world
everi
year
lead
seriou
threat
public
health
especi
children
elderli
addit
influenza
viru
potenc
caus
sever
pandem
econom
loss
outbreak
avian
influenza
china
caus
nearli
billion
loss
economi
current
synthet
antivir
drug
vaccin
limit
use
develop
countri
due
emerg
resist
strain
high
cost
harm
side
effect
howev
antiinfluenza
agent
deriv
herb
mani
advantag
low
cost
toxic
extens
sourc
eas
access
moreov
herbal
drug
usual
multitarget
effect
act
antivir
agent
also
stimul
immun
therefor
medicin
plant
extract
phytochem
attract
attent
potenti
sourc
develop
new
antivir
drug
recent
decad
woad
root
common
name
ban
lan
gen
dri
root
plant
isati
indigotica
fort
woad
root
first
document
herbal
drug
divin
husbandman
herbal
foundat
canon
famou
ancient
medic
book
han
dynasti
china
ad
use
treatment
cold
sore
throat
headach
hundr
year
china
woad
root
use
prevent
sever
acut
respiratori
syndrom
sar
swine
flu
pandem
china
hong
kong
taiwan
japan
flu
vaccin
main
prophylact
treatment
winter
protect
influenza
virus
estim
billion
spent
flu
vaccin
product
everi
year
feder
govern
usa
therefor
necessari
develop
inexpens
drug
effect
prophylact
activ
use
water
extract
woad
root
prevent
cold
document
hundr
year
recent
antivir
effect
methanol
water
ethyl
ester
extract
woad
root
confirm
vitro
test
howev
mode
antivir
action
extract
still
clear
addit
littl
inform
differ
antivir
action
singl
pure
compound
extract
compound
isol
phenylpropanoid
pep
alkaloid
organ
acid
three
major
chemic
portion
woad
root
clemastanin
b
cb
abund
compound
belong
phenylpropanoid
epigoitrin
main
alkaloid
compound
isol
woad
root
figur
previou
screen
show
cb
epigoitrin
strong
inhibitori
effect
influenza
viru
object
present
studi
elucid
possibl
antiinfluenza
mechan
cb
epigoitrin
compar
phenylpropanoid
portion
mixtur
phenylpropanoid
alkaloid
organ
acid
portion
pep
alk
oa
mous
lungadapt
variant
influenza
viru
strain
obtain
depart
microbiolog
immunolog
shandong
univers
viru
propag
twice
allanto
caviti
embryon
hen
egg
c
h
enhanc
virul
allanto
fluid
harvest
measur
hemagglutin
activ
hemagglutin
titer
reach
viru
aliquot
store
c
use
madindarbi
canin
kidney
mdck
cell
human
cervic
cancer
hela
cell
obtain
institut
cell
biolog
chines
academi
scienc
posit
control
ribavirin
batch
number
purchas
baili
pharmaceut
co
ltd
sichuan
provinc
china
woad
root
collect
anhui
provinc
china
herb
identif
confirm
morpholog
microscop
analysi
accord
chines
pharmacopeia
extract
pure
compound
chemic
portion
woad
root
conduct
tianjin
sunnypeak
biotech
co
ltd
mixtur
phenylpropanoid
alkaloid
organ
acid
portion
pep
alk
oa
prepar
mix
portion
ratio
www
lyophil
materi
directli
resuspend
cell
cultur
medium
filter
steril
membran
compound
dissolv
medium
first
dissolv
dmso
dilut
fresh
medium
final
dmso
concentr
medium
less
concentr
cb
epigoitrin
gml
initi
concentr
pep
pep
alk
oa
gml
antiinfluenza
action
cb
epigoitrin
chemic
portion
woad
root
extract
investig
four
differ
mode
therapeut
action
prophylaxi
direct
viru
inactiv
inhibit
viru
attach
cell
preinfect
viru
pure
compound
chemic
portion
plant
extract
ad
therapeut
action
drug
evalu
cytopath
effect
cpe
reduct
assay
cell
mtt
assay
cpe
reduct
assay
conduct
accord
previou
report
slight
modif
briefli
quadrupl
mdck
monolay
cell
plate
infect
ml
suspens
contain
tcid
tissu
cultur
infect
dose
viru
h
unabsorb
viru
wash
use
pb
quadrupl
cell
monolay
subsequ
overlaid
ml
medium
contain
differ
nontox
twofold
serial
dilut
pure
compound
chemic
portion
woad
root
extract
cell
viru
infect
without
drug
treatment
cell
without
viru
drug
use
control
plate
incub
c
co
h
virusinduc
cpe
observ
light
microscop
comparison
parallel
viru
control
cell
control
mtt
reduct
assay
perform
accord
standard
protocol
short
experiment
setup
procedur
cpe
assay
day
incub
l
mtt
ad
well
evidencebas
complementari
altern
medicin
incub
c
h
subsequ
dmso
ad
absorb
measur
nm
cell
protect
rate
calcul
follow
formula
see
evalu
effect
pure
compound
chemic
portion
woad
extract
prophylaxi
cell
infect
mdck
monolay
cell
plate
overlaid
differ
nontox
twofold
serial
dilut
pure
compound
chemic
portion
woad
root
extract
four
replic
set
treatment
control
h
test
substanc
remov
well
monolay
cell
infect
tcid
influenza
viru
c
h
allow
viru
absorpt
subsequ
unabsorb
viru
wash
use
pb
equal
amount
mainten
medium
ad
well
plate
incub
c
co
h
virusinduc
cpe
observ
light
microscop
direct
virucid
activ
pure
compound
chemic
portion
woad
extract
test
accord
method
describ
carlucci
et
al
one
hundr
microlit
tcid
viru
treat
equal
volum
twofold
dilut
pure
compound
extract
portion
h
c
sampl
tenfold
serial
dilut
confluent
monolay
mdck
cell
form
surviv
viru
mixtur
determin
cpe
assay
titer
tcid
valu
calcul
accord
reedmuench
method
assay
monolay
mdck
cell
cultur
plate
one
hundr
microlit
differ
nontox
twofold
serial
dilut
pure
compound
chemic
portion
woad
root
extract
equal
volum
tcid
viru
simultan
ad
mdck
cell
incub
h
c
virusextract
mixtur
remov
well
mainten
medium
ad
plate
incub
c
co
h
virusinduc
cpe
observ
light
microscop
experi
repeat
three
time
quintupl
determin
data
express
mean
sd
student
test
perform
compar
control
treatment
valu
consid
signific
differ
consid
signific
portion
woad
root
extract
order
investig
therapeut
effect
influenza
viru
cell
preinfect
viru
h
follow
addit
antivir
compound
chemic
portion
woad
root
extract
solvent
blank
cb
epigoitrin
chemic
portion
woad
root
extract
obviou
cytotox
data
shown
therapeut
action
evalu
cpe
assay
mtt
assay
clear
cytopath
effect
observ
mdck
cell
infect
hour
increas
gap
cell
ruptur
cell
nucleu
partial
complet
collaps
cell
figur
viru
control
viru
control
group
cpe
observ
see
tabl
supplementari
materi
avail
onlin
http
howev
mdck
cell
grow
well
drug
treatment
group
figur
ribavirin
pep
alk
oa
portion
group
cpe
format
complet
inhibit
dilut
tabl
mtt
reduct
assay
show
addit
cb
epigoitrin
pep
pep
alk
oa
portion
woad
root
extract
significantli
increas
viabil
mdck
cell
preinfect
viru
compar
viru
control
group
dilut
figur
b
molecular
mechan
clemastanin
b
epigoitrin
antivir
activ
fulli
understood
recent
report
show
clemastanin
b
might
target
viral
endocytosi
retain
ribonucleoprotein
rnp
influenza
viru
nucleu
interestingli
protect
rate
four
treatment
group
significantli
higher
posit
control
ribavirin
group
dilut
indic
compound
extract
portion
woad
root
better
therapeut
action
influenza
viru
current
commerci
synthet
antivir
drug
ribavirin
addit
protect
effect
cb
epigoitrin
pep
pep
alk
oa
portion
dosedepend
highest
protect
rate
observ
dilut
cb
epigoitrin
mixtur
pep
alk
oa
portion
pep
dilut
result
highest
cell
viabil
figur
c
comparison
differ
treatment
group
mixtur
pep
alk
oa
portion
highest
cell
protect
rate
portion
woad
root
extract
order
evalu
effect
pure
compound
chemic
portion
woad
root
extract
prophylaxi
influenza
viru
mdck
cell
treat
serial
dilut
cb
epigoitrin
pep
pep
alk
oa
portion
respect
h
drug
remov
well
cell
infect
tcid
cpe
format
observ
cell
viabil
measur
mtt
assay
cpe
assay
show
obviou
cpe
format
mdck
cell
pretreat
cb
epigoitrin
pep
pep
alk
oa
portion
dilut
tabl
shown
tabl
pretreat
either
pure
compound
chemic
portion
woad
root
extract
dilut
significantli
improv
viabil
mdck
cell
moreov
compar
ribavirin
natur
compound
extract
wood
root
higher
prophylact
activ
influenza
viru
cell
viabil
dosedepend
increas
pep
pep
alk
oa
portion
tabl
contrast
protect
rate
cell
viabil
significantli
chang
dilut
cb
epigoitrin
among
four
differ
natur
product
use
studi
pep
portion
show
signific
protect
effect
cell
protect
rate
evidencebas
complementari
altern
medicin
extract
next
investig
effect
cb
epigoitrin
pep
pep
alk
oa
portion
inactiv
influenza
viru
c
cell
without
treatment
shown
figur
viru
control
figur
b
mdck
cell
infect
influenza
viru
cocultur
cb
epigoitrin
pep
pep
alk
oa
show
pyknosi
condens
even
lysi
figur
c
f
surviv
viru
titer
tcid
experiment
group
howev
posit
control
ribavirin
inhibit
cpe
format
complet
dilut
level
figur
g
observ
reveal
cb
epigoitrin
pep
pep
alk
oa
could
directli
inactiv
influenza
viru
even
concentr
dilut
previou
studi
hsuan
et
al
also
found
inhibit
pseudorabi
viru
methanol
extract
woad
leav
extract
due
direct
viru
inactiv
attach
influenza
viru
attach
primarili
mediat
two
type
glycoprotein
call
hemagglutinin
neuraminidas
studi
investig
whether
natur
occur
compound
chemic
portion
woad
extract
inhibit
viru
attach
host
cell
result
cpe
assay
list
tabl
cpe
format
drug
treatment
group
even
lowest
concentr
dilut
result
suggest
cb
epigoitrin
pep
pep
alk
oa
portion
strong
inhibitori
effect
bind
influenza
viru
mdck
cell
viabil
mdck
cell
h
infect
viru
simultan
treatment
natur
compound
determin
mtt
reduct
assay
shown
tabl
viabil
mdck
cell
significantli
increas
result
drug
treatment
compar
viru
control
inhibit
viru
adsorpt
host
cell
cb
epigoitrin
pep
dosedepend
manner
maximum
inhibitori
effect
cb
epigoitrin
pep
observ
dilut
result
time
increas
cell
viabil
respect
contrast
highest
cell
protect
rate
pep
alk
oa
posit
control
ribavirin
group
found
dilut
addit
shown
cb
epigoitrin
pep
pep
alk
oa
effect
ribavirin
inhibit
influenza
viru
attach
tabl
compar
four
natur
compound
chemic
portion
observ
pep
portion
dilut
possess
maximum
inhibitori
effect
viru
absorpt
led
highest
protect
classic
defin
antivir
mechan
medicin
plant
includ
inhibit
viru
replic
block
viru
attach
direct
inactiv
viru
prevent
viru
infect
studi
clearli
demonstr
cb
epigoitrin
pep
pep
alk
oa
show
antiinfluenza
activ
therapeut
action
inhibit
viru
multipl
prophylaxi
inhibit
viru
attach
howev
differ
observ
major
mode
antivir
action
differ
compound
chemic
portion
figur
instanc
highest
cell
protect
rate
pep
pep
alk
oa
therapeut
action
figur
pep
pep
alk
oa
main
antiinfluenza
mode
epigoitrin
inhibit
viru
multipl
viru
attach
figur
epigoitrin
epigoitrin
contrast
three
mode
antivir
action
cb
contribut
equal
cell
protect
rate
cb
major
phenylpropanoid
compound
woad
root
epigoitrin
abund
alkaloid
indic
qualiti
control
woad
root
previou
studi
report
overal
viru
inhibitori
effect
green
tea
stronger
plant
total
extract
singl
pure
compound
extract
due
possibl
synergist
interact
ingredi
extract
howev
result
suggest
chang
antivir
activ
might
differ
antivir
mechan
singl
compound
mixtur
extract
present
studi
mode
antiinfluenza
action
chemic
portion
constitu
woad
root
extract
investig
result
reveal
cb
epigoitrin
pep
pep
alk
oa
demonstr
antiinfluenza
activ
therapeut
action
prophylaxi
cell
inhibit
viru
attach
compound
chemic
portion
test
direct
virucid
activ
main
antivir
mode
pep
pep
alk
oa
therapeut
action
epigoitrin
mainli
inhibit
viru
multipl
attach
knowledg
first
report
antivir
mechan
compound
chemic
portion
woad
root
extract
